Boccadoro M - Search Results

1

Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features.

Isoardo G, Bergui M, Durelli L, Barbero P, Boccadoro M, Bertola A, Ciaramitaro P, Palumbo A, Bergamasco B, Cocito D. Isoardo G, et al. Among authors: boccadoro m. Acta Neurol Scand. 2004 Mar;109(3):188-93. doi: 10.1034/j.1600-0404.2003.00203.x. Acta Neurol Scand. 2004. PMID: 14763956

2

Multiple myeloma: a tailored therapy for elderly patients.

Pileri A, Palumbo A, Boccadoro M. Pileri A, et al. Among authors: boccadoro m. Hematol Oncol. 1993;11 Suppl 1:67-72. Hematol Oncol. 1993. PMID: 8486344 Review. No abstract available.

3

Interferon-gamma in multiple myeloma.

Palumbo A, Bruno B, Boccadoro M, Pileri A. Palumbo A, et al. Among authors: boccadoro m. Leuk Lymphoma. 1995 Jul;18(3-4):215-9. doi: 10.3109/10428199509059610. Leuk Lymphoma. 1995. PMID: 8535185 Review.

4

Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.

Palumbo A, Giaccone L, Bertola A, Pregno P, Bringhen S, Rus C, Triolo S, Gallo E, Pileri A, Boccadoro M. Palumbo A, et al. Among authors: boccadoro m. Haematologica. 2001 Apr;86(4):399-403. Haematologica. 2001. PMID: 11325646 Clinical Trial.

5

New developments and treatment in multiple myeloma: new drugs in the treatment of multiple myeloma.

Boccadoro M, Palumbo A. Boccadoro M, et al. Ann Oncol. 2002;13 Suppl 4:55-8. doi: 10.1093/annonc/mdf639. Ann Oncol. 2002. PMID: 12401667 Free article. Review. No abstract available.

6

Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m(2)).

Palumbo A, Bringhen S, Bertola A, Cavallo F, Falco P, Massaia M, Bruno B, Rus C, Barbui A, Caravita T, Musto P, Pescosta N, Rossini F, Vignetti M, Boccadoro M. Palumbo A, et al. Among authors: boccadoro m. Leukemia. 2004 Jan;18(1):133-8. doi: 10.1038/sj.leu.2403196. Leukemia. 2004. PMID: 14586481 Clinical Trial.

7

Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.

Palumbo A, Boccadoro M, Garino LA, Gallone G, Frieri R, Pileri A. Palumbo A, et al. Among authors: boccadoro m. Eur J Haematol. 1992 Aug;49(2):93-7. doi: 10.1111/j.1600-0609.1992.tb00037.x. Eur J Haematol. 1992. PMID: 1397246 Clinical Trial.

8

Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.

Palumbo AP, Garino AL, Frieri R, Gallone G, Boccadoro M, Pileri A. Palumbo AP, et al. Among authors: boccadoro m. Haematologica. 1990 Nov-Dec;75(6):576-8. Haematologica. 1990. PMID: 2098302

9

Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma.

Palumbo A, Boccadoro M, Bruno B, Triolo S, Pileri A. Palumbo A, et al. Among authors: boccadoro m. Haematologica. 1994 Nov-Dec;79(6):513-8. Haematologica. 1994. PMID: 7534745 Clinical Trial.

10

Interferon plus glucocorticoids as intensified maintenance therapy prolongs tumor control in relapsed myeloma.

Palumbo A, Boccadoro M, Garino LA, Gallone G, Frieri R, Pileri A. Palumbo A, et al. Among authors: boccadoro m. Acta Haematol. 1993;90(2):71-6. doi: 10.1159/000204379. Acta Haematol. 1993. PMID: 8285021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

515 results

Search Page

Filters